This inventor holds 1 USPTO granted patent. Top assignee: Merck Canada Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Jean-Francois Chiasson
Introduction
Jean-Francois Chiasson is a notable inventor based in St-Constant, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. His work has the potential to impact the treatment and prevention of HIV and AIDS.
Latest Patents
Chiasson holds a patent for compounds that function as HIV protease inhibitors. The patent details compounds of Formula I, which include various defined components that are effective in treating HIV infections. These compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of HIV and can be combined with other antivirals, immunomodulators, antibiotics, or vaccines.
Career Highlights
Chiasson is associated with Merck Canada Inc., where he has been involved in groundbreaking research and development. His work in the pharmaceutical industry has led to advancements in HIV treatment options, showcasing his commitment to improving public health.
Collaborations
Some of his notable coworkers include Michael John Boyd and Sheldon N Crane. Their collaboration has likely contributed to the innovative research and development efforts at Merck Canada Inc.
Conclusion
Jean-Francois Chiasson is a prominent figure in the field of pharmaceutical innovation, particularly in the area of HIV treatment. His contributions through patents and collaboration with esteemed colleagues highlight his dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile